Tl. Bowersock et al., INHIBITION OF STAPHYLOCOCCI BY VANCOMYCIN ABSORBED ON TRIIDODECYLMETHYL AMMONIUM CHLORIDE-COATED INTRAVENOUS CATHETER, Journal of controlled release, 31(3), 1994, pp. 237-243
Catheter-related infections are a serious problem in hospitalized pati
ents. Triidodecylmethyl ammonium chloride (TDMAC)treated catheters wer
e absorbed with the antibiotic vancomycin and evaluated for bactericid
al activity against Staphylococcus aureus and Staphylococcus epidermid
is over time. Bactericidal activity occurred in a biphasic pattern wit
h peak activity from 0-72 h and activity detectable for up to 6 days.
Incubation of the TDMAC-coated catheters in serum did not reduce the b
actericidal activity of vancomycin bound to the catheter for Staphyloc
occi. These results document that TDMAC-coated catheters could be used
to absorb vancomycin thereby expanding the range of antibiotics avail
able for binding to surfactant-treated catheters. The use of vancomyci
n would be helpful in preventing catheter infections by highly antibio
tic-resistant organisms such as the Staphylococci, especially in sites
such as the brain where effective concentration of other parenterally
administered antibiotics is difficult to attain.